Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-03-29
2010-02-02
Chen, Shin-Lin (Department: 1632)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S023500, C536S024100, C536S024500
Reexamination Certificate
active
07655780
ABSTRACT:
ILK genetic sequences and methods of use are provided. In some embodiments, a fragment or portion of an ILK polynucleotide is provided, where the polynucleotide has a sequence consisting of contiguous nucleotides within the provided ILK sequences, which may be within the provided ILK coding sequences. Such polynucleotides may be DNA, RNA, and the like, and may be double stranded or single stranded.
REFERENCES:
patent: 6001622 (1999-12-01), Dedhar et al.
patent: WO 94/21781 (1994-09-01), None
patent: WO 96/00760 (1996-01-01), None
patent: WO 96/36642 (1996-11-01), None
patent: WO 97/23625 (1997-07-01), None
Clark et al., 2003, EST Accession No. AY411993 (computer printout pp. 18-20).
Li et al., 2004, EST Accession No. AL555417, (computer printout pp. 26-27).
Hirling et al., 1992, Nucleic Acid Research, vol. 20, No. 1, p. 33-39.
Dedhar, S., “Integrin mediated signal transduction in oncogenesis: an overview,” (1995)Cancer and Metasis Reviews, 14:165-172.
Dedhar, S., et al., “Integrin cytoplasmic interactions and bidirectional transmembrane signaling,” (1996)Current Opinion Cell Biol., 8:559-657.
Gimond, et al., (1995)Exp. Cell Res., 216:232-235.
Givskov, et al., (1990) Swiss Prot—38 Accession P18954.
Genbank Accession No. H70160.
Genbank Accession No. R91874.
Hannigan, et al., “Regulation of cell adhesion and anchorage dependent growth by a new beta I integrin linked protein kinase,” (1996)Nature379:91-96.
Hannigan, et al., “Overexpression of a novel integrin linked kinase (ILK) induces a transformed phenotype and cyclin D1 expression,” (1995)Molecular Biology of the Cell, 6:2244.
Hannigan, et al., “Cloning of a novel protein kinase associated with beta I integrin cytoplasmic tails,” (1995)80thAnnual Meeting of the American Association for Cancer Research, P:361.
Kappel, C., et al., (1992)Current Opinion in Biotechnology, 3:548-553.
Lin, T., et al., “Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells,” (1995)The Journal of Biological Chemistry, 270(27):16189-16197.
Liao, L., et al., “Effect of α-protein kinase C, neutralizing antibodies and the pseudosubstrate peptide on phosphorylation, migration and growth of REF52 cells,” (1993)Cell Growth and Differentiation, 4:309-316.
Dedhar, S., et al. (1997) Geneseq Accession No. AAT71716, computer printout, pp. 4-5.
Adams, et al. (1997) EST Accession No. AA295328, computer printout, p. 2.
Hillier, et al. (1997) EST Accession No. AA135079, computer printout, pp. 6-7.
Hillier, et al. (1995) Genbank Accession No. R14703, pp. 4-5.
Ozaki, et al. (1993) Genbank Accession No. D13973, pp. 12-13.
Dedhar Shoukat
Hannigan Gregory E.
Bozicevic Field & Francis LLP
Chen Shin-Lin
Sherwood Pamela J.
Sunnybrook and Women's College and Health Science Centre
LandOfFree
Integrin-linked kinase and its uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Integrin-linked kinase and its uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin-linked kinase and its uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4233170